October 7, 2025

10x Genomics, Inc. (TXG)

⚠️ No article content returned.

..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 107.81% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, has captured investor attention with its potential upside of 107.81%. This compelling figure is driven by a combination of..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating the Virtual Healthcare Landscape with a 6.48% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) is carving out a significant niche in the rapidly evolving virtual healthcare sector. As a leader in health information services, Teladoc offers a comprehensive suite..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating Challenges with Strategic Insights for Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a name that resonates within the healthcare sector, particularly in the medical devices industry. With a market capitalization of $1.13 billion, this U.S.-based..

Novavax, Inc. (NVAX) Investor Outlook: Navigating a 37.67% Potential Upside in the Biotech Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has been at the forefront of vaccine innovation, especially in the wake of the COVID-19 pandemic. With its cutting-edge..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring an 81.83% Potential Upside in the Biotech Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is capturing investor interest in the biotechnology sector, primarily due to its ambitious development pipeline and the significant potential upside of 81.83% as suggested by..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

AdaptHealth Corp. (AHCO) Stock Analysis: A 46% Potential Upside Ignites Investor Interest

AdaptHealth Corp. (NASDAQ: AHCO), a notable player in the healthcare sector, is making waves in the medical devices industry with its robust array of home medical equipment and related services...

Structure Therapeutics Inc. (GPCR): Analyst Ratings Point to a 155% Upside, Propelling Investor Interest

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with remarkable potential upside, as underscored by its analyst ratings. This United States-based biotechnology company, operating within the healthcare..

Phreesia, Inc. (PHR) Stock Analysis: Growth Potential in Health Information Services with a 44.8% Upside

Phreesia, Inc. (NYSE: PHR), a prominent player in the healthcare sector, is gaining considerable attention from investors due to its robust growth potential and significant analyst optimism. With its current..

Dynavax Technologies Corp (DVAX) Stock Analysis: Exploring a 124.85% Potential Upside for Investors

Dynavax Technologies Corporation (NASDAQ: DVAX) has been a company of interest for investors seeking opportunities in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With..

Opko Health, Inc. (OPK) Stock Analysis: A High-Stakes Bet with 129% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, is making waves in the diagnostics and pharmaceuticals industries. Headquartered in Miami, Florida, the company has made significant..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges with a Diverse Product Portfolio

BGM Group Ltd. (BGM), a company nestled in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, is making waves with its diverse range of pharmaceutical..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring Growth Potential with 9.89% Upside

In the ever-evolving healthcare sector, NeoGenomics, Inc. (NEO) stands out as a prominent player within the diagnostics and research industry. With a robust presence in the United States and the..

89bio, Inc. (ETNB) Stock Analysis: Unveiling a 97% Potential Upside in the Biotech Sector

For investors keeping a keen eye on the biotech sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing opportunity. With a market capitalization of $2.21 billion, this clinical-stage biopharmaceutical company is..

Premier, Inc. (PINC) Stock Analysis: Examining the 3.02% Dividend Yield Amidst a Challenging Revenue Landscape

Investors eyeing opportunities in the healthcare sector may want to consider Premier, Inc. (NASDAQ: PINC), a firm that operates in the health information services industry. With a market capitalization of..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 31.66% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a key player in the healthcare sector, is currently drawing investor attention with a compelling 31.66% potential upside, according to analyst projections. Operating within..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 22.90% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector specializing in drug manufacturing with a focus on specialty and generic products, presents a compelling narrative for investors...

Evolent Health, Inc (EVH) Stock Analysis: Exploring an 87% Potential Upside in Healthcare Tech

Evolent Health, Inc (NASDAQ: EVH) stands out as a compelling opportunity for investors interested in the healthcare technology sector. Operating at the intersection of health information services and specialty care..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Biotech Play with 41% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) has captured the attention of investors in the biotechnology sector, thanks to its promising pipeline and a notable potential upside. Headquartered in Altrincham, United Kingdom,..

Search

Funds

October 7, 2025

Search

Funds

October 7, 2025

FTSE 100

Funds